Helga Westerlind

3.1k total citations
54 papers, 877 citations indexed

About

Helga Westerlind is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Helga Westerlind has authored 54 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 22 papers in Pathology and Forensic Medicine and 11 papers in Genetics. Recurrent topics in Helga Westerlind's work include Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (18 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Helga Westerlind is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (25 papers), Systemic Lupus Erythematosus Research (18 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Helga Westerlind collaborates with scholars based in Sweden, Iceland and United States. Helga Westerlind's co-authors include Jan Hillert, Lars Alfredsson, Marie Holmqvist, Lars Klareskog, Ryan Ramanujam, Saedís Saevarsdóttir, Johan Askling, Roger Hesselstrand, Marios Rossides and Ali Manouchehrinia and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Helga Westerlind

49 papers receiving 865 citations

Peers

Helga Westerlind
Paula I. Burgos Chile
Thorsten Krieger Germany
Fady Joseph United Kingdom
Tünde Csépány Hungary
Liviu Georgescu United States
J. Deans United Kingdom
Ellen Kim United States
Gavin McDonnell United Kingdom
Andreas Lossius Norway
Lisa Costelloe Ireland
Paula I. Burgos Chile
Helga Westerlind
Citations per year, relative to Helga Westerlind Helga Westerlind (= 1×) peers Paula I. Burgos

Countries citing papers authored by Helga Westerlind

Since Specialization
Citations

This map shows the geographic impact of Helga Westerlind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helga Westerlind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helga Westerlind more than expected).

Fields of papers citing papers by Helga Westerlind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helga Westerlind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helga Westerlind. The network helps show where Helga Westerlind may publish in the future.

Co-authorship network of co-authors of Helga Westerlind

This figure shows the co-authorship network connecting the top 25 collaborators of Helga Westerlind. A scholar is included among the top collaborators of Helga Westerlind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helga Westerlind. Helga Westerlind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saevarsdóttir, Saedís, Lina-Marcela Díaz-Gallo, Lars Alfredsson, et al.. (2023). Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis. Lara D. Veeken. 63(5). 1221–1229. 1 indexed citations
3.
Saevarsdóttir, Saedís, Vivek Anand Manivel, Lars Klareskog, et al.. (2023). In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the Rheumatic Diseases. 83(3). 277–287. 20 indexed citations
4.
Westerlind, Helga, Bente Glintborg, Hilde Berner Hammer, et al.. (2023). Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts. RMD Open. 9(3). e003027–e003027. 11 indexed citations
5.
Brynedal, Boel, Niyaz Yoosuf, Daniel Ziemek, et al.. (2023). Molecular signature of methotrexate response among rheumatoid arthritis patients. Frontiers in Medicine. 10. 1146353–1146353. 5 indexed citations
6.
Westerlind, Helga, et al.. (2022). Investigation of the association between coffee and risk of RA—results from the Swedish EIRA study. Arthritis Research & Therapy. 24(1). 178–178. 2 indexed citations
7.
Westerlind, Helga, Alf Kastbom, Johan Rönnelid, et al.. (2022). The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis. Lara D. Veeken. 62(6). 2106–2112. 4 indexed citations
8.
Westerlind, Helga, et al.. (2022). Incidence and prevalence of systemic sclerosis in Sweden, 2004–2015, a register-based study. Seminars in Arthritis and Rheumatism. 53. 151978–151978. 7 indexed citations
9.
Igelström, Helena, et al.. (2022). Physical activity and sport-specific training patterns in Swedish sporting and working trial dogs—A questionnaire survey. Frontiers in Veterinary Science. 9. 976000–976000. 6 indexed citations
10.
Díaz-Gallo, Lina-Marcela, Boel Brynedal, Helga Westerlind, Rickard Sandberg, & Daniel Ramsköld. (2021). Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations. PLoS ONE. 16(4). e0250282–e0250282. 13 indexed citations
11.
Rossides, Marios, et al.. (2021). Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Lara D. Veeken. 60(7). 3121–3133. 111 indexed citations
12.
Westerlind, Helga, et al.. (2021). Is tea consumption associated with reduction of risk of rheumatoid arthritis? A Swedish case-control study. Arthritis Research & Therapy. 23(1). 209–209. 12 indexed citations
13.
Westerlind, Helga, Marie Holmqvist, Lotta Ljung, Thomas Frisell, & Johan Askling. (2019). Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome. Annals of the Rheumatic Diseases. 78(5). 683–687. 5 indexed citations
14.
Terao, Chikashi, Boel Brynedal, Xia Jiang, et al.. (2019). Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype. The American Journal of Human Genetics. 105(3). 616–624. 30 indexed citations
15.
Manouchehrinia, Ali, Helga Westerlind, Elaine Kingwell, et al.. (2017). Age Related Multiple Sclerosis Severity Score: Disability ranked by age. Multiple Sclerosis Journal. 23(14). 1938–1946. 102 indexed citations
16.
Folkersen, Lasse, Boel Brynedal, Lina-Marcela Díaz-Gallo, et al.. (2016). Integration of Known DNA, RNA and Protein Biomarkers Provides Prediction of Anti-TNF Response in Rheumatoid Arthritis: Results from the COMBINE Study. Molecular Medicine. 22(1). 322–328. 37 indexed citations
17.
Westerlind, Helga, Ryan Ramanujam, Ralf Kuja‐Halkola, et al.. (2014). Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain. 137(3). 770–778. 101 indexed citations
18.
Westerlind, Helga, Ryan Ramanujam, Kjell‐Morten Myhr, et al.. (2014). Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. European Journal of Human Genetics. 23(5). 688–692. 13 indexed citations
19.
Link, Jenny, Ingrid Kockum, Åslaug Rudjord Lorentzen, et al.. (2012). Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis. PLoS ONE. 7(5). e36779–e36779. 44 indexed citations
20.
Lundström, Wangko, Eva Greiner, Frida Lundmark, et al.. (2011). No influence on disease progression of non-HLA susceptibility genes in MS. Journal of Neuroimmunology. 237(1-2). 98–100. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula I. Burgos Breakdown of academic impact, for papers by Thorsten Krieger Breakdown of academic impact, for papers by Fady Joseph Breakdown of academic impact, for papers by Tünde Csépány Breakdown of academic impact, for papers by Liviu Georgescu Breakdown of academic impact, for papers by J. Deans Breakdown of academic impact, for papers by Ellen Kim Breakdown of academic impact, for papers by Gavin McDonnell Breakdown of academic impact, for papers by Andreas Lossius Breakdown of academic impact, for papers by Lisa Costelloe
Rankless by CCL
2026